Research On The Optimization Of Hengrui Pharmaceutical Operating Capital Management Under The Strategic Transformation

As the main body of the national economy,the strength of a country’s manufacturing industry is closely related to the quality of life of the people,and it is related to the national strength and international status of the country.Since the reform and opening up,China’s manufacturing industry has continued to develop,and has gradually formed a complete,independent and complete industrial system,which has greatly promoted China’s industrialization and modernization process,and significantly enhanced China’s overall national strength and international status.However,compared with the world’s advanced level,China’s manufacturing enterprises are still at the lowest end of the "smile curve",which is a veritable "manufacturing power & brand small country." In order to get out of this predicament,the state encourages all walks of life to actively innovate,but in the process of innovation,enterprise management will face some problems more or less.One of the problems is how to adjust the original working capital management related strategies in the face of enterprise innovation and business upgrading.Ensuring that companies can grow more aggressively.As the largest R&D base for anti-tumor drug production in China,Hengrui Medicine has been actively investing in the research and development of innovative drugs since the early days.In recent years,R&D efforts have been continuously increased.On this basis,compared with other companies in the same industry,its management of working capital is not as superior as its leading position,and there are still some areas for improvement.The second chapter of the thesis first expounds the basic theories such as the concept and characteristics of working capital,and then sorts out the relevant documents of working capital management.On this basis,it integrates the working capital performance management system proposed by the predecessors and makes appropriate combination.The working capital management system under the dual perspectives of factor channels.Finally,this paper sorts out the relevant literature on enterprise working capital management under strategic transformation,and naturally leads to the innovation of this paper.The third chapter introduces the basic situation of Hengrui Medicine and the basic situation of its strategic transformation.It uses the vertical comparison method and relevant indicators to analyze the working capital status of the enterprise during the transition period,and then draws the strategic transformation to the management of enterprise working capital.related requirements.The fourth chapter is to use the method of horizontal comparison to compare the relevant indicators of Hengrui Medicine in the transition period with the other four companies in the same industry from the perspective of factors and channels,which may lead to the possible problems of Hengrui Medicine,and at the end of the chapter.Conduct an in-depth analysis of it.The fifth chapter uses the fishbone diagram to propose the optimization plan for the problems in the fourth chapter,and finally draws the complete set of optimization suggestions for the management of Hengrui Pharmaceutical’s working capital under the strategic transformation.Through the vertical comparison and horizontal comparison methods,this paper deeply analyzes the working capital management status of enterprises in a dynamic environment,and concludes that under the strategic transformation,Hengrui Medicine’s working capital management should be combined with the emerging channel perspective.Fully consider the importance of enterprise R&D activities in the management of working capital channels,and seek the external optimization conclusions from the perspective of pursuing the optimization of internal management mode,in the hope of providing working capital management for the scale transformation of related industries.Aspect of the reference.